Abstract
The NMDA receptor plays a significant role in development and maintenance of pain. It is implicated in the development of neuropathic pain, reduced opioid responsiveness, hyperalgesia, and the transition from acute to chronic pain. Hence the NMDA receptor presents an attractive analgesic target for both acute and chronic pain states. This chapter discusses the molecular neurophysiologic mechanisms that mediate the significance of the NMDA receptor. It describes the potential analgesic role of NMDA-receptor antagonists such as ketamine, memantine, amantadine, dextromethorphan, and methadone. The mechanisms, pharmacokinetics, and clinical efficacy of NMDA-receptor antagonists are reviewed in detail. Clinical pearls for the practical use of the NMDA-receptor antagonists are also provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
Aiyer R, Mehta N, Gungor S, Gulati A. A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice. Clin J Pain. 2018;34(5):450–67.
Badiola IJ. Can chronic pain be prevented? Anesthesiol Clin. 2016;34(2):303–15.
Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2017;6:CD003351.
Connolly SB, Prager JP, Harden RN. A systematic review of ketamine for complex regional pain syndrome. Pain Med. 2015;16(5):943–69.
Maher DP, Chen L, Mao J. Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization. Anesth Analg. 2017;124(2):661–74.
Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059–77.
Pourmand A, Mazer-Amirshahi M, Royall C, Alhawas R, Shesser R. Low dose ketamine use in the emergency department, a new direction in pain management. Am J Emerg Med. 2017;35(6):918–21.
Quibell R, Fallon M, Mihalyo M, Twycross R, Wilcock A. Ketamine. J Pain Symptom Manag. 2015;50(2):268–78.
Sawynok J. Topical and peripheral ketamine as an analgesic. Anesth Analg. 2014;119(1):170–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kamdar, M.M. (2019). Ketamine and NMDA-Receptor Antagonists. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-12281-2_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12280-5
Online ISBN: 978-3-030-12281-2
eBook Packages: MedicineMedicine (R0)